正文：
中新网上海5月19日电 (记者 陈静)中国炎症性肠病(IBD)患者人数不断增加，给患者、家庭和社会带来负担，其诊疗过程如同一场马拉松，一旦确诊患者将面临终身治疗。
炎症性肠病(IBD)是一类以慢性炎症性改变为特征的肠道疾病，包括克罗恩病(CD)和溃疡性结肠炎(UC)。随着人们生活节奏加快、饮食结构改变，炎症性肠病的发病率呈上升趋势。据估计，中国炎症性肠病患者已超过100万，而且这一数字还在不断增长。
“炎症性肠病的治疗是一个长期而复杂的过程，患者需要定期服药、接受检查和手术治疗，这对他们的生活质量造成了很大影响。”上海交通大学医学院附属仁济医院消化科主任陈勤教授说。
近年来，小分子药物的发展为炎症性肠炎患者的治疗提供了新的可能。小分子药物具有靶点明确、作用机制简单、副作用小的特点，能够有效改善患者的症状，提高生活质量。
“小分子药物的使用，让炎症性肠病患者有了更多的治疗选择，他们的治疗达标率得到了提高。”陈勤教授表示，未来，随着更多的小分子药物上市，炎症性肠病的治疗将更加精准、有效，患者的痛苦也将得到更好的缓解。
此外，专家提醒，炎症性肠病患者在治疗过程中，应该积极配合医生的治疗，保持良好的生活习惯，避免辛辣、油腻食物的摄入，同时，保持良好的心态，积极面对疾病，争取早日康复。
英语如下：
Title: “Small Molecule Drugs Offer New Hope for Patients with Inflammatory Bowel Disease”
Keywords: Small molecule drugs, Inflammatory bowel disease, Treatment goals achieved.
News Content:
Title: Small Molecule Drugs Help Inflammatory Bowel Disease Patients Achieve Treatment Goals – Expert
Body:
SHANGHAI, May 19 (Xinhua) — The number of patients with Inflammatory Bowel Disease (IBD) in China is increasing, imposing a burden on patients, families, and society. The diagnostic and treatment process is like a marathon, with patients facing lifelong treatment once diagnosed.
Inflammatory Bowel Disease (IBD) is a group of intestinal diseases characterized by chronic inflammatory changes, including Crohn’s Disease (CD) and Ulcerative Colitis (UC). As people’s lifestyles become faster-paced and dietary structures change, the incidence of IBD is on the rise. It is estimated that there are over 10 million patients with inflammatory bowel disease in China, and this number is still growing.
“The treatment of inflammatory bowel disease is a long and complex process. Patients need regular medication, checks, and surgery, which greatly affects their quality of life,” said Professor Chen Qin, the head of the Digestive Department of Renji Hospital, Shanghai Jiao Tong University School of Medicine.
In recent years, the development of small molecule drugs has provided new possibilities for the treatment of inflammatory bowel disease. Small molecule drugs have clear targets, simple mechanisms of action, and fewer side effects, effectively improving patients’ symptoms and enhancing their quality of life.
“The use of small molecule drugs has given inflammatory bowel disease patients more treatment options, and their treatment success rates have improved,” Professor Chen Qin said. In the future, with more small molecule drugs coming on the market, the treatment of inflammatory bowel disease will be more precise and effective, providing better relief of patients’ suffering.
Additionally, experts remind patients with inflammatory bowel disease that during treatment, they should actively cooperate with doctors, maintain good habits, avoid spicy and greasy foods, and maintain a positive mindset to face the disease and strive for early recovery.
【来源】http://www.chinanews.com/life/2024/05-19/10219608.shtml
Views: 6